Bibliographic Details
| Title: |
Effect of fasting plasma glucose level in severe fever and thrombocytopenia syndrome patients without diabetes. |
| Authors: |
Pan, Jun1 (AUTHOR) 1318356775@qq.com, Yang, Zhihao1 (AUTHOR), Xu, Wen1 (AUTHOR), Tian, Shan2 (AUTHOR), Liu, Xiaobo1 (AUTHOR) 1318356775@qq.com, Guo, Chunxia2 (AUTHOR) 1318356775@qq.com |
| Superior Title: |
PLoS Neglected Tropical Diseases. 4/16/2024, Vol. 18 Issue 4, p1-13. 13p. |
| Subject Terms: |
*BLOOD sugar, *GLUCOSE metabolism disorders, *HYPERGLYCEMIA, *GLYCEMIC control, *PEOPLE with diabetes, *PROGNOSIS |
| Abstract: |
Hyperglycemia is correlated with worse in-hospital outcomes in acute infectious diseases such as coronavirus disease 2019 (COVID-19) and severe fever with thrombocytopenia syndrome (SFTS). This study assessed the relationship between fasting plasma glucose (FPG) levels and in-hospital mortality, disease type, and secondary infections among individuals with SFTS without preexisting diabetes. The clinical data and laboratory results upon admission of 560 patients with SFTS without preexisting diabetes meeting the inclusion criteria at Wuhan Union Hospital were collected. FPG levels in surviving patients with SFTS subjects were significantly lower than those in patients with SFTS who had died (P<0.0001). In multivariate Cox regression, high FPG level (≥11.1 mmol/L) was a risk factor independently associated with the in-hospital death of patients with SFTS without preexisting diabetes. Similarly, the FPG levels in general patients with SFTS were significantly lower than those in patients with severe SFTS (P<0.0001). Multivariate logistic regression identified high FPG level (7.0–11.1 mmol/L) as a risk factor independently associated with SFTS severity. While FPG levels were comparable between patients with SFTS with and without secondary infection (P = 0.5521), logistic regression analysis revealed that high FPG levels were not a risk factor for secondary infection in patients with SFTS without preexisting diabetes. High FPG level on admission was an independent predictor of in-hospital death and severe disease in individuals with SFTS without preexisting diabetes. FPG screening upon admission and glycemic control are effective methods for improving the prognosis of patients with SFTS. Author summary: Diabetes is a risk factor for a less favorable prognosis in patients with cancer or autoimmune diseases, but few studies have explored the association between fasting plasma glucose (FPG) levels and in-hospital mortality, disease type, and secondary infections among individuals with severe fever and thrombocytopenia syndrome (SFTS). Our study reveal that high FPG level on admission was an independent predictor of in-hospital death and severe disease in individuals with SFTS without preexisting diabetes. FPG screening upon admission and glycemic control are effective methods to assess the prognosis and disease type of patients with SFTS regardless of diabetes status, as most individuals with SFTS are prone to glucose metabolism disorders. [ABSTRACT FROM AUTHOR] |
|
Copyright of PLoS Neglected Tropical Diseases is the property of Public Library of Science and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Premier |
|
Full text is not displayed to guests. |
Login for full access.
|